© The Rockefeller University Press, 0022-1007/1997/11/1609/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 9, November 3, 1997 1609-1614
Generation of Lytic Natural Killer 1.1+, Ly-49– Cells from Multipotential Murine Bone Marrow Progenitors in a Stroma-free Culture: Definition of Cytokine Requirements and Developmental Intermediates
Noelle Sevilir Williams*,
Thomas A. Moore
,
John D. Schatzle*,
Igor J. Puzanov*,
P.V. Sivakumar*,
Albert Zlotnik
,
Michael Bennett*, and
Vinay Kumar*
From the * Laboratory of Molecular Pathology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9072; and
Immunology Department, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304-1104
We have developed a stroma-free culture system in which mouse marrow or thymus cells, known to be enriched for lymphoid progenitors, can be driven to generate natural killer (NK) cells. Culture of lineage marker (Lin)–, c-kit+, Sca2+, interleukin (IL)-2/15Rβ (CD122)– marrow cells in IL-6, IL-7, stem cell factor (SCF), and flt3 ligand (flt3-L) for 5–6 d followed by IL-15 alone for an additional 4–5 d expanded the starting population 30–40-fold and gave rise to a virtually pure population of NK1.1+, CD3– cells. Preculture in IL-6, IL-7, SCF, and flt3-L was necessary for inducing IL-15 responsiveness in the progenitors because the cells failed to significantly expand when cultured in IL-15 alone from the outset. Although culture of the sorted progenitors in IL-6, IL-7, SCF, and flt3-L for the entire 9–11-d culture period caused significant expansion, no lytic NK1.1+ cells were generated if IL-15 was not added, demonstrating a critical role for IL-15 in NK differentiation. Thus, two distinct populations of NK progenitors, IL-15 unresponsive and IL-15 responsive, have been defined. Similar results were obtained with Lin–, CD44+, CD25–, c-kit+ lymphoid progenitors obtained from adult thymus. The NK cells generated by this protocol lysed the NK-sensitive target YAC-1 and expressed markers of mature NK cells with the notable absence of Ly-49 major histocompatibility complex (MHC) receptors. However, despite the apparent lack of these inhibitory MHC receptors, the NK cells generated could distinguish MHC class I+ from class I– syngeneic targets, suggesting the existence of novel class I receptors.
Address correspondence to Dr. Noelle S. Williams, Laboratory of Molecular Pathology, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9072. Phone: 214-648-4081; FAX: 214-648-4033; E-mail: williams.n{at}pathology.swmed.edu

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Castillo, E. F., Stonier, S. W., Frasca, L., Schluns, K. S.
(2009). Dendritic Cells Support the In Vivo Development and Maintenance of NK Cells via IL-15 Trans-Presentation. J. Immunol.
183: 4948-4956
[Abstract]
[Full Text]
-
Mallidi, T. V., Craig, L. E., Schloemann, S. R., Riley, J. K.
(2009). Murine Endometrial and Decidual NK1.1+ Natural Killer Cells Display a B220+CD11c+ Cell Surface Phenotype. Biol. Reprod.
81: 310-318
[Abstract]
[Full Text]
-
Yadi, H., Burke, S., Madeja, Z., Hemberger, M., Moffett, A., Colucci, F.
(2008). Unique Receptor Repertoire in Mouse Uterine NK cells. J. Immunol.
181: 6140-6147
[Abstract]
[Full Text]
-
Freud, A. G., Yokohama, A., Becknell, B., Lee, M. T., Mao, H. C., Ferketich, A. K., Caligiuri, M. A.
(2006). Evidence for discrete stages of human natural killer cell differentiation in vivo. JEM
203: 1033-1043
[Abstract]
[Full Text]
-
Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M., Kumar, V.
(2004). 2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells. JEM
199: 1245-1254
[Abstract]
[Full Text]
-
Schluns, K. S., Nowak, E. C., Cabrera-Hernandez, A., Puddington, L., Lefrancois, L., Aguila, H. L.
(2004). Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor {alpha} expression. Proc. Natl. Acad. Sci. USA
101: 5616-5621
[Abstract]
[Full Text]
-
Garrison, S., Hojgaard, A., Margraf, R., Weis, J. J., Weis, J. H.
(2003). Surface Translocation of Pactolus Is Induced by Cell Activation and Death, but Is Not Required for Neutrophil Migration and Function. J. Immunol.
171: 6795-6806
[Abstract]
[Full Text]
-
Kawamura, T., Koka, R., Ma, A., Kumar, V.
(2003). Differential Roles for IL-15R {alpha}-Chain in NK Cell Development and Ly-49 Induction. J. Immunol.
171: 5085-5090
[Abstract]
[Full Text]
-
Barlic, J., Sechler, J. M., Murphy, P. M.
(2003). IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood
102: 3494-3503
[Abstract]
[Full Text]
-
Toomey, J. A., Gays, F., Foster, D., Brooks, C. G.
(2003). Cytokine requirements for the growth and development of mouse NK cells in vitro. J. Leukoc. Biol.
74: 233-242
[Abstract]
[Full Text]
-
Stevenaert, F., Van Beneden, K., De Creus, A., Debacker, V., Plum, J., Leclercq, G.
(2003). Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors. J. Leukoc. Biol.
73: 731-738
[Abstract]
[Full Text]
-
Perez, S. A., Sotiropoulou, P. A., Gkika, D. G., Mahaira, L. G., Niarchos, D. K., Gritzapis, A. D., Kavalakis, Y. G., Antsaklis, A. I., Baxevanis, C. N., Papamichail, M.
(2003). A novel myeloid-like NK cell progenitor in human umbilical cord blood. Blood
101: 3444-3450
[Abstract]
[Full Text]
-
Jiang, K., Zhong, B., Ritchey, C., Gilvary, D. L., Hong-Geller, E., Wei, S., Djeu, J. Y.
(2003). Regulation of Akt-dependent cell survival by Syk and Rac. Blood
101: 236-244
[Abstract]
[Full Text]
-
Minagawa, M., Watanabe, H., Miyaji, C., Tomiyama, K., Shimura, H., Ito, A., Ito, M., Domen, J., Weissman, I. L., Kawai, K.
(2002). Enforced Expression of Bcl-2 Restores the Number of NK Cells, But Does Not Rescue the Impaired Development of NKT Cells or Intraepithelial Lymphocytes, in IL-2/IL-15 Receptor {beta}-Chain-Deficient Mice. J. Immunol.
169: 4153-4160
[Abstract]
[Full Text]
-
McMahon, C. W., Zajac, A. J., Jamieson, A. M., Corral, L., Hammer, G. E., Ahmed, R., Raulet, D. H.
(2002). Viral and Bacterial Infections Induce Expression of Multiple NK Cell Receptors in Responding CD8+ T Cells. J. Immunol.
169: 1444-1452
[Abstract]
[Full Text]
-
Lian, R. H., Maeda, M., Lohwasser, S., Delcommenne, M., Nakano, T., Vance, R. E., Raulet, D. H., Takei, F.
(2002). Orderly and Nonstochastic Acquisition of CD94/NKG2 Receptors by Developing NK Cells Derived from Embryonic Stem Cells In Vitro. J. Immunol.
168: 4980-4987
[Abstract]
[Full Text]
-
Shimozato, O., Ortaldo, J. R., Komschlies, K. L., Young, H. A.
(2002). Impaired NK Cell Development in an IFN-{gamma} Transgenic Mouse: Aberrantly Expressed IFN-{gamma} Enhances Hematopoietic Stem Cell Apoptosis and Affects NK Cell Differentiation. J. Immunol.
168: 1746-1752
[Abstract]
[Full Text]
-
Loza, M. J., Zamai, L., Azzoni, L., Rosati, E., Perussia, B.
(2002). Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood
99: 1273-1281
[Abstract]
[Full Text]
-
Yoshida, H., Kawamoto, H., Santee, S. M., Hashi, H., Honda, K., Nishikawa, S., Ware, C. F., Katsura, Y., Nishikawa, S.-I.
(2001). Expression of {alpha}4{beta}7 Integrin Defines a Distinct Pathway of Lymphoid Progenitors Committed to T Cells, Fetal Intestinal Lymphotoxin Producer, NK, and Dendritic Cells. J. Immunol.
167: 2511-2521
[Abstract]
[Full Text]
-
Kunz, B., Held, W.
(2001). Positive and Negative Roles of the Trans-Acting T Cell Factor-1 for the Acquisition of Distinct Ly-49 MHC Class I Receptors by NK Cells. J. Immunol.
166: 6181-6187
[Abstract]
[Full Text]
-
Hung, C.-F., Hsu, K.-F., Cheng, W.-F., Chai, C.-Y., He, L., Ling, M., Wu, T-C.
(2001). Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to a Gene Encoding the Extracellular Domain of Fms-like Tyrosine Kinase 3-Ligand. Cancer Res.
61: 1080-1088
[Abstract]
[Full Text]
-
Fehniger, T. A., Suzuki, K., Ponnappan, A., VanDeusen, J. B., Cooper, M. A., Florea, S. M., Freud, A. G., Robinson, M. L., Durbin, J., Caligiuri, M. A.
(2001). Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells. JEM
193: 219-232
[Abstract]
[Full Text]
-
Fehniger, T. A., Caligiuri, M. A.
(2001). Interleukin 15: biology and relevance to human disease. Blood
97: 14-32
[Full Text]
-
Braun, S. E., Chen, K., Foster, R. G., Kim, C. H., Hromas, R., Kaplan, M. H., Broxmeyer, H. E., Cornetta, K.
(2000). The CC Chemokine CK{beta}-11/MIP-3{beta}/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK Cells. J. Immunol.
164: 4025-4031
[Abstract]
[Full Text]
-
Colucci, F., Di Santo, J. P.
(2000). The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells. Blood
95: 984-991
[Abstract]
[Full Text]
-
Toomey, J. A., Salcedo, M., Cotterill, L. A., Millrain, M. M., Chrzanowska-Lightowlers, Z., Lawry, J., Fraser, K., Gays, F., Robinson, J. H., Shrestha, S., Dyson, P. J., Brooks, C. G.
(1999). Stochastic Acquisition of Qa1 Receptors During the Development of Fetal NK Cells In Vitro Accounts in Part But Not in Whole for the Ability of These Cells to Distinguish Between Class I-Sufficient and Class I-Deficient Targets. J. Immunol.
163: 3176-3184
[Abstract]
[Full Text]
-
Williams, N. S., Klem, J., Puzanov, I. J., Sivakumar, P. V., Bennett, M., Kumar, V.
(1999). Differentiation of NK1.1+, Ly49+ NK Cells from flt3+ Multipotent Marrow Progenitor Cells. J. Immunol.
163: 2648-2656
[Abstract]
[Full Text]
-
Sivakumar, P. V., Gunturi, A., Salcedo, M., Schatzle, J. D., Lai, W. C., Kurepa, Z., Pitcher, L., Seaman, M. S., Lemonnier, F. A., Bennett, M., Forman, J., Kumar, V.
(1999). Cutting Edge: Expression of Functional CD94/NKG2A Inhibitory Receptors on Fetal NK1.1+Ly-49- Cells: A Possible Mechanism of Tolerance During NK Cell Development. J. Immunol.
162: 6976-6980
[Abstract]
[Full Text]
-
Iizuka, K., Chaplin, D. D., Wang, Y., Wu, Q., Pegg, L. E., Yokoyama, W. M., Fu, Y.-X.
(1999). Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl. Acad. Sci. USA
96: 6336-6340
[Abstract]
[Full Text]
-
Chang, C. S., Brossay, L., Kronenberg, M., Kane, K. P.
(1999). The Murine Nonclassical Class I Major Histocompatibility Complex-like CD1.1 Molecule Protects Target Cells from Lymphokine-activated Killer Cell Cytolysis. JEM
189: 483-491
[Abstract]
[Full Text]
-
Carlyle, J. R., Zuniga-Pflucker, J. C.
(1998). Regulation of NK1.1 Expression During Lineage Commitment of Progenitor Thymocytes. J. Immunol.
161: 6544-6551
[Abstract]
[Full Text]
-
Yu, H., Fehniger, T. A., Fuchshuber, P., Thiel, K. S., Vivier, E., Carson, W. E., Caligiuri, M. A.
(1998). Flt3 Ligand Promotes the Generation of a Distinct CD34+ Human Natural Killer Cell Progenitor That Responds to Interleukin-15. Blood
92: 3647-3657
[Abstract]
[Full Text]
-
Shaw, S. G., Maung, A. A., Steptoe, R. J., Thomson, A. W., Vujanovic3, N. L.
(1998). Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with Flt3-Ligand: Implications for Anti-Cancer and Anti-Viral Therapy. J. Immunol.
161: 2817-2824
[Abstract]
[Full Text]